The ease of acquiring prior authorizations for a new formulary drug plays a part in evaluating oncology drugs that are new to the market.
Andrea Iannucci, PharmD, BCOP
Advertisement
Assistant Chief Pharmacist, UC Davis Health
Articles by Andrea Iannucci, PharmD, BCOP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Cicada COVID-19 Variant FAQs: Symptoms, Risk, and Prevention
2
Oz White House Briefing Touts Drug Savings and Fraud Cleanup, but Data Tell a Nuanced Story
3
Plastic in Personal Care Products Tied to Skin Disease and Environmental Pollution, Review Finds
4
Three Years on Baricitinib Preserved Hair Regrowth in Severe Alopecia Areata
5